Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AGBL1 antisense RNA 1 (AGBL1-AS1) is a long non-coding RNA gene located on chromosome 15q25.3. It does not code for a protein but is transcribed as RNA. While the adjacent protein-coding gene AGBL1 has been implicated in rare cases of Fuchs endothelial corneal dystrophy, the antisense RNA itself currently lacks direct associations with disease mechanisms, biomarker utility, or known pharmacological targeting. Its detailed biological functions, mechanisms, and clinical relevance remain to be elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AGBL1 antisense RNA 1 (AGBL1-AS1).